Matches in Wikidata for { <http://www.wikidata.org/entity/Q64354045> ?p ?o ?g. }
Showing items 1 to 30 of
30
with 100 items per page.
- Q64354045 description "clinical trial" @default.
- Q64354045 description "ensayu clínicu" @default.
- Q64354045 description "klinisch onderzoek" @default.
- Q64354045 description "клінічне випробування" @default.
- Q64354045 name "A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients" @default.
- Q64354045 type Item @default.
- Q64354045 label "A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients" @default.
- Q64354045 prefLabel "A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients" @default.
- Q64354045 P1132 Q64354045-C8C6F62C-2914-440B-8FDD-6B16752A7434 @default.
- Q64354045 P1476 Q64354045-009F7E20-8D87-4E2B-A1C5-8F96D83613A6 @default.
- Q64354045 P17 Q64354045-54E86575-5ED5-4F95-A5E6-31E559BF3647 @default.
- Q64354045 P2899 Q64354045-178F7B6B-BA0B-458A-A948-D92970DE744D @default.
- Q64354045 P3098 Q64354045-44354B2B-BD51-400E-A657-F2186A6A50F4 @default.
- Q64354045 P31 Q64354045-2599F091-F1A9-4560-A6A0-F178CD703C4F @default.
- Q64354045 P4135 Q64354045-5F8F2CE7-0421-40BD-A77C-B4487F56DADB @default.
- Q64354045 P580 Q64354045-08A5855F-643F-4A52-A050-F4C38FB90AB3 @default.
- Q64354045 P582 Q64354045-1B183F12-0C03-4491-80C8-B71B6F9F9ABB @default.
- Q64354045 P6099 Q64354045-F5931469-5B3A-4AB9-9B4D-D5431218995D @default.
- Q64354045 P8363 Q64354045-1CFEB871-4F8D-4C37-BEE7-5ECD9BAB7956 @default.
- Q64354045 P1132 "+69" @default.
- Q64354045 P1476 "A Randomized-Controlled Three-arm Phase II Study of Lurbinectedin (PM01183) Alone or In Combination With Gemcitabine and a Control Arm With Docetaxel as Second-Line Treatment in Unresectable Non-Small Cell Lung Cancer (NSCLC) Patients" @default.
- Q64354045 P17 Q30 @default.
- Q64354045 P2899 "+18" @default.
- Q64354045 P3098 "NCT01951157" @default.
- Q64354045 P31 Q30612 @default.
- Q64354045 P4135 "+75" @default.
- Q64354045 P580 "2013-10-01T00:00:00Z" @default.
- Q64354045 P582 "2016-11-01T00:00:00Z" @default.
- Q64354045 P6099 Q42824440 @default.
- Q64354045 P8363 Q78089383 @default.